Affirmative Palliative Care for Transgender and Gender Nonconforming Individuals.
Megan Pfitzinger Lippe, Joshua C Eyer, Kailey E Roberts and 5 others
PMID 36951345WHAT IT FOUND
Nurses caring for transgender and gender nonconforming patients at the end of life should actively ask patients to define their own family, document name and pronoun preferences respectfully, and review medications for gender-affirming therapies to prevent unsafe polypharmacy.
Key findings
01Nurses should consistently ask all patients their name and pronouns, use them in all conversations, and document gender identity preferences in the electronic health record according to patient wishes.
02Nurses must facilitate opportunities for patients to autonomously define who counts as family, including chosen family, and advocate for these individuals to be included in care planning and advance directives.
03Nurses are responsible for obtaining accurate medication histories that include gender-affirming therapies and collaborating with interdisciplinary teams to manage polypharmacy risks and potential drug interactions.
STILL TO COME
How it was doneWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a consensus-based guideline document, not a study of patient outcomes. It reports no data on whether these practices improve health or satisfaction. The recommendations are based on expert opinion and existing literature reviews, which may not capture the full diversity of experiences across all TGNC populations.
Declared interests
The authors have disclosed no potential conflicts of interest, financial or otherwise.
The easy way to misread this
Do not treat these recommendations as evidence that specific interventions improve patient outcomes. This is a set of suggested practices based on expert consensus and existing guidelines, not the results of a clinical trial or observational study.